Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 2 of 30
-
Civil Society Challenges the New Patent Law at the Indonesian Constitutional Court
Patent evergreening refers to various tactics employed by companies to prolong patent protection in order to maintain market monopolies and...
-
MMA Partner Celebrates Milestone in Opposing Evergreening of TB Drug Patents in Vietnam
The Intellectual Property Office of Vietnam revoked claims 1-19, 21-23, and 25-32 by J&J, stating that J&J’s argument to patent...
-
Fundación GEP Marks Landmark Wins on Lenacapavir and Cabotegravir for Affordable HIV Prevention and Treatment in Argentina
The filing of oppositions is a fundamental strategic line of the FGEP’s Health Access Program, which allows the prevention and...
-
No Borders, No Barriers: Communities Call for Universal Access to Lenacapavir
Lenacapavir – a twice-yearly HIV prevention injection – could transform the fight against HIV. But Gilead’s restrictive voluntary license excludes...
-
Activists Demand $40-a-year Generic Price for Breakthrough HIV Prevention Drug be Made Available to all Low- and Middle-Income Countries
A global coalition reacted to two deals announced today to make long acting lenacapavir (LEN-LA), a 6 monthly HIV PrEP...
-
UN High-Level Meeting on NCDs: Declaration Without Affordability Is Just Empty Words
Weaknesses in the Draft Declaration Civil society groups warn that the latest draft does not reference the right of governments...
-
Procurement Non-Transparency, Overreliance on Donors, and Lacking Political Will for Local Production: Recent Africa Market Intelligence Analysis
The reports, published by the Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN – Kenya), Community Health...
-
ITPC Global Hosts Summit, Marking 30 years of Global Injustice
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit brought together over 100 activists, policymakers, and researchers...
-
Brazil’s ABIA Leads Fight Against Patent Barriers to HIV, TB and Other Life-Saving Medicines
Through its Working Group on Intellectual Property (GTPI), ABIA has filed more than 40 oppositions since 2006 against patents on...
-
New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention
Lenacapavir, administered just twice a year, has been shown to reduce HIV transmission to nearly zero. However, the drug’s high...
-
A look into the findings of the Market Intelligence Study for Uganda
In full recognition of the gloom that hovers around the withdrawal of funds, allow me shed a little light to...
-
Ever-greening Patents – a Common Trick of Big Pharma, and Access to MDR TB Drug in Thailand
Chalermsak Kittitrakul, TNP+’s Project Manager for Access to Medicines, said, “The civil society’s movement on opposing the patent applications for...